glp-1 gip mechanism of action The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1 and GIP receptor signaling
Description
The publisher does not endorse, control, or take responsibility for content on third-party websites, and inclusion of an external link does not imply any affiliation, endorsement, or partnership
60 HolstJJGromadaJNauckMA
These results may inform research into psychiatric safety and potential repurposing opportunities for GLP-1RAs, especially in people with mental health disorders, but randomized clinical trials are needed to determine whether the genetic associations translate into treatment benefits
Even a mild imbalance can cause deep fatigue
